Last fall, I had the pleasure of seeing Jewel perform as part of a spectacular day of fundraising for brain research at One Mind Institute’sMusic Festival for Brain Health in Napa, California. I was instantly transported back to my 17-year-old self, sitting with my brother in a beach town coffee shop that served as our home away from home. Captivated week after week by Jewel’s musical storytelling of her escape from a childhood spent in the Alaskan wilderness, my brother and I had no idea that life would imminently transform for each of us, thrusting our family into the untamed wild of the mental healthcare system.
Jewel would soon be discovered in the coffee shop, quickly becoming a Grammy-nominated artist, an abrupt change from living in her car, unable to afford bottled drinking water. My brother, a newly minted Marine, would soon begin acting strangely, pull away from his family and friends, and ultimately be committed to the first of many long term hospital stays, where he would be diagnosed with paranoid schizophrenia.
Twenty years later, a lot has changed for the nine million Americans like my brother who are living with serious brain health challenges, but not nearly enough.
It is now well understood that mental illness is the chief health issue for teens and young adults:
75% of mental illnesses manifest before age 24. Psychiatric disorders are the #1 disease burden for ages 10-24.
Untreated mental health problems put us at risk for a myriad of life threatening health issues, including suicide, the2nd leading cause of death for 15-24 year olds in the United States.
Yet, only half of teens and young adults get the treatment they need and deserve. In partnership with One Mind Institute (IMHRO) and with an incredible team at my side, I’ve brought Partners for StrongMinds to life to change that.
Oncologists don’t wait to see how stage 1 cancer progresses before starting treatment. In the same manner, we cannot afford to ignore ‘stage 1’ psychosis, a condition affecting the processing of thoughts and sensory information that is highly treatable in its early stages. When treated early with a complementary set of social supports, low-dose medication (as needed) and structured talk therapies, the progression of psychosis into a chronic or debilitating condition can be prevented.
Based on a large body of international evidence supporting specialty care for early psychosis, this highly individualized, empowering treatment model is making it possible for young people experiencing psychosis to get back to school, work and chasing their dreams.
If I knew then what I know now, I might have been able to at least question whether changes in my brother’s behavior were related to changes in his brain, given a well-established history of mental illness in our family (that, like most families, was rarely discussed). I would have understood the importance of treatment that aimed beyond simply muting my brother’s delusions and hallucinations, but also focused on regaining cognitive function and social skills – the things that would have allowed him to retain his identity, confidence and independence.
For my brother, becoming well enough to be discharged from an inpatient unit meant that he was interested in living, and showed fewer outward symptoms of psychosis. However, hospital discharge also came with heavy doses of medication that left him feeling numb, or, in his words, like he was “constantly drowning,” and included no follow up care. It did not mean he was prepared to go to college, or apply for a job, or regain his friendships; nor did he believe that these things were possible, as we were repeatedly told by his many doctors that they were not.
Around the time our family’s journey began with psychosis, early treatment programs began spreading across Europe, Australia and Canada. Two decades later, the United States is finally catching up, now nearing 100 programs offered across the country. A recently published landmark U.S. study underscores the benefits of early treatment for psychosis: significant improvement in symptoms, quality of life and increased involvement in work and school. In 2005, the World Health Organization came to the same conclusion, noting a more than 50% reduction in symptoms for early treatment participants. Now that the clinical landscape is shifting, public awareness about psychosis and its treatability must drastically improve if we are to reach more young people in the early stages of a mental health crisis.
Today, we know better, and we must do better.
In a lot of ways, starting P4SM makes me feel like a 17-year-old all over again: I’m finally following a dream to align my work with my passion – using my voice to empower the voiceless. Walking away from a stable, lucrative corporate career to work toward brighter futures for young people was a big, scary and continually life-affirming leap of faith. Thank you all for catching me.
I hope you will join the P4SM community in taking action to ensure more young people get the right kind of treatment and support when it matters most.
“If I could tell the world just one thing
It would be that we’re all OK
And not to worry ’cause worry is wasteful
And useless in times like these
I won’t be made useless
I won’t be idle with despair
I will gather myself around my faith
For light does the darkness most fear”
As Founding Director, Chantel Garrett leads Partners for StrongMinds (P4SM) in demystifying one of the most misunderstood health conditions - psychosis - so that more young people get the right kind of help when it matters most.
She brings fifteen years as a marketer in the for-profit sector, where she held leadership roles in both large and small financial institutions, last serving as director of messaging and sales strategy for the iShares division of Blackrock.
Inspired byher brother’s experience living with schizophrenia, Chantel is translating her business background into advocacy efforts for radical change in the quality, delivery, and social embrace of mental health care.